FDA approves Regeneron's Pasatru for rare bone disorder FOP
Go back to FDA approves Regeneron's Pasatru for rare bone disorder FOP| Regeneron (NASDAQ: REGN) | Delayed: 798.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $798.17 | 52 Week High | $592.36 | |||
| Open | $798.17 | 52 Week Low | $325.35 | |||
| Day High | $798.17 | P/E | 209.49 | |||
| Day Low | $798.17 | EPS | $3.81 | |||
| Volume | 216 | |||||
